Polysaccharide peptide from Coriolus versicolor induces interleukin 6-related extension of endotoxin fever in rats

References

• Zaidman BZ, Yassin M, Mahajna J, Wasser SP. Medicinal mushroom modulators of molecular targets as cancer therapeutics. Appl Microbiol Biotechnol 2005;67:453–68
   PubMed Web of Science ®Google Scholar
• Cheng KF, Leung PC. General review of polysaccharopeptides (PSP) from C. versicolor: Pharmacological and clinical studies. Cancer Ther 2008;6:117–30
   Google Scholar
• Chan SL, Yeung JH. Polysaccharide peptides from COV-1 strain of Coriolus versicolor induce hyperalgesia via inflammatory mediator release in the mouse. Life Sci 2006;78:2463–70
   PubMed Web of Science ®Google Scholar
• Dong Y, Kwan CY, Chen ZN, Yang MM. Antitumor effects of a refined polysaccharide peptide fraction isolated from Coriolus versicolor: in vitro and in vivo studies. Res Commun Mol Pathol Pharmacol 1996;92:140–8
   PubMed Web of Science ®Google Scholar
• Ng TB. A review of research on the protein-bound polysaccharide (polysaccharopeptide, PSP) from the mushroom Coriolus versicolor (Basidiomycetes: Polyporaceae). Gen Pharmacol 1998;30:1–4
   PubMedGoogle Scholar
• Schepetkin IA, Quinn MT. Botanical polysaccharides: Macrophage immunomodulation and therapeutic potential. Int Immunopharmacol 2006;6:317–33
   PubMed Web of Science ®Google Scholar
• Sekhon BK, Sze DM, Chan WK, Fan K, Li GQ, Moore DE, et al. PSP activates monocytes in resting human peripheral blood mononuclear cells: Immunomodulatory implications for cancer treatment. Food Chem 2013;138:2201–9
   PubMed Web of Science ®Google Scholar
• IUPS Thermal Commission. Glossary of terms for thermal physiology, 3rd ed. Jpn J Physiol 2001;51:245–80
   Google Scholar
• Kluger MJ, Kozak W, Conn CA, Leon LR, Soszynski D. The adaptive value of fever. Infect Dis Clin North Am 1996;10:1–21
   PubMed Web of Science ®Google Scholar
• Roberts Jr NJ. The immunological consequences of fever. In: Mackowiak PA, editors Fever: Basic Mechanisms and Management. New York: Raven Press, 1991. p 125--42
   Google Scholar
• Kluger MJ. Fever: role of pyrogens and cryogens. Physiol Rev 1991;71:93–127
   PubMed Web of Science ®Google Scholar
• DalNagore AR, Sharma S. Exogenous pyrogens. In: Mackowiak PA, editors Fever: Basic Mechanism and Management, 2nd ed. Philadelphia: Raven-Lippincott, 1997. pp 87–116
   Google Scholar
• Kozak W, Wrotek S, Kozak A. Pyrogenicity of CpG-DNA in mice: Role of interleukin-6, cyclooxygenases, and nuclear factor-κB. Am J Physiol Regul Integr Comp Physiol 2006;290:R871–80
   PubMed Web of Science ®Google Scholar
• Kozak W, Kluger MJ, Tesfaigzi J, Wachulec M, Kozak A, Dokladny K. Molecular mechanisms of fever and endogenous antipyresis. Ann N Y Acad Sci 2000;917:121–34
   PubMed Web of Science ®Google Scholar
• Kluger MJ, Leon LR, Kozak W, Soszynski D, Conn CA. Cytokine actions on fever. In: Rothwell NJ, editors Cytokines in the Nervous System. Austin, TX: Landes, 1996. pp 73–92
   Google Scholar
• Netea MG, Kullberg BJ, van der Meer JWM. Circulating cytokines as mediators of fever. Clin Infect Dis 2000;31:S178–84
   PubMed Web of Science ®Google Scholar
• Blatteis CM, Li S, Li Z, Feledr C, Perlik V. Cytokines, PGE2 and endotoxic fever: A reassessment. Prostagl Lipid Mediat 2005;76:1–18
   PubMed Web of Science ®Google Scholar
• Jedrzejewski T, Piotrowski J, Wrotek S, Kozak W. Polysaccharide peptide induces a tumor necrosis factor-α-dependent drop of body temperature in rats. J Therm Biol 2014;44:1–4
   PubMed Web of Science ®Google Scholar
• Wrotek S, Jedrzejewski T, Potera-Kram E, Kozak W. Antipyretic activity of N-acetylcysteine. J Physiol Pharmacol 2011;62:669–75
   PubMed Web of Science ®Google Scholar
• Kozak W, Kluger MJ, Soszynski D, Conn CA, Rudolph K, Leon LR, et al. IL-6 and IL-1 beta in fever. Studies using cytokine-deficient (knockout) mice. Ann N Y Acad Sci 1998;856:33–47
   PubMed Web of Science ®Google Scholar
• Chai Z, Gatti S, Toniatti C, Poli V, Bartfai T. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1β: A study on IL-6-deficient mice. J Exp Med 1996;183:311–16
   PubMed Web of Science ®Google Scholar
• Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, Gros P, et al. Endotoxin-tolerant mice have mutations in Toll-like receptor 4(TLR4). J Exp Med 1999;189:615–25
   PubMed Web of Science ®Google Scholar
• Fenton MJ, Golenbock DT. LPS-binding proteins and receptors. J Leuk Biol 1988;64:25–32
   Google Scholar
• Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990;249:1431–33
   PubMed Web of Science ®Google Scholar
• Li W, Liu M, Lai S, Xu C, Lu F, Xia X, et al. Immunomodulatory effects of polysaccharopeptide (PSP) in human PBMC through regulation of TRAF6/TLR immunosignal-transduction pathways. Immunopharmacol Immunotoxicol 2010;32:576–84
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Karin M. Nuclear factor-κB, a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066–71
   PubMed Web of Science ®Google Scholar
• O’Neill LA, Bowie A. The family of five: TIR-domain-containing adaptors in Toll-like receptor signaling. Nat Rev Immunol 2007;7:353–64
   PubMed Web of Science ®Google Scholar
• Wang J, Dong B, Tan Y, Yu S, Bao YX. A study on the immunomodulation of polysaccharopeptide through the TLR4-TIRAP/MAL-MyD88 signaling pathway in PBMCs from breast cancer patients. Immunopharmacol Immunotoxicol 2013;35:497–504
   PubMed Web of Science ®Google Scholar
• Fisher M, Yang LX. Anticancer effects and mechanisms of polysaccharide-K (PSK): Implications of cancer immunotherapy. Anticancer Res 2002;22:1737–54
   PubMed Web of Science ®Google Scholar
• Kim BC, Kim YS, Lee JW, Seo JH, Ji ES, Lee H, et al. Protective effect of Coriolus versicolor cultivated in citrus extract against nitric oxide-induced apoptosis in human neuroblastoma SK-N-MC cells. Exp Neurobiol 2011;20:100–9
   Google Scholar
• Yang SF, Zhuang TF, Si YM, Qi KY, Zhao J. Coriolus versicolor mushroom polysaccharides exert immunoregulatory effects on mouse B cells via membrane Ig and TLR-4 to activate the MAPK and NF-κB signaling pathways. Mol Immunol 2015;64:144–51
   PubMed Web of Science ®Google Scholar
• Barton GM, Medzhitov R. Toll-like receptor signaling pathways. Science 2003;300:1524–5
   PubMed Web of Science ®Google Scholar
• Baldassare JJ, Bi Y, Bellone CJ. The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. J Immunol 1999;162:5367–73
   PubMed Web of Science ®Google Scholar
• Greenhill CJ, Gould J, Ernst M, Jarnicki A, Hertzog PJ, Mansell A, et al. LPS hypersensitivity of gp130 mutant mice is independent of elevated haemopoietic TLR4 signaling. Immunol Cell Biol 2012;90:559–63
   PubMed Web of Science ®Google Scholar
• Bode JG, Schweigart J, Kehrmann J, Ehlting C, Schaper F, Heinrich PC, et al. TNF–alpha induces tyrosine phosphorylation and recruitment of the Src homology protein-tyrosine phosphatase 2 to the gp130 signal-transducing subunit of the IL-6 receptor complex. J Immunol 2003;171:257–66
   PubMed Web of Science ®Google Scholar
• Greenhill CJ, Rose-John S, Lissilaa R, Ferlin W, Ernst M, Hertzog PJ, et al. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. J Immunol 2011;186:1199–208
   PubMed Web of Science ®Google Scholar
• Horwood NJ, Page TH, McDaid JP, Palmer CD, Campbell J, Mahon T, et al. Bruton’s tyrosine kinase is required for TLR2 and TLR4-induced TNF, but not IL-6, production. J Immunol 2006;176:3635–41
   PubMed Web of Science ®Google Scholar
• Chen Y, Kam CS, Liu FQ, Liu Y, Lui VC, Lamb JR, et al. LPS-induced up-regulation of TGF-beta receptor 1 is associated with TNF-alpha expression in human monocyte-derived macrophages. J Leukoc Biol 2008;83:1165–73
   PubMed Web of Science ®Google Scholar
• Samavati L, Rastogi R, Du W, Hüttemann M, Fite A, Franchi L. STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. Mol Immunol 2009;46:1867–77
   PubMed Web of Science ®Google Scholar
• Prêle CM, Keith-Magee AL, Murcha M, Hart PH. Activated signal transducer and activator of transcription-3 (STAT3) is a poor regulator of tumour necrosis factor-alpha production by human monocytes. Clin Exp Immunol 2007;147:564–72
   PubMed Web of Science ®Google Scholar
• Ghezzi P, Sacco S, Agnello D, Marullo A, Caselli G, Bertini R. LPS induces IL-6 in the brain and in serum largely through TNF production. Cytokine 2000;12:1205–10
   PubMed Web of Science ®Google Scholar
• Benigni F, Faggioni R, Sironi M, Fantuzzi G, Vandenabeele P, Takahashi N, et al. TNF receptor p55 plays a major role in centrally mediated increases of serum IL-6 and corticosterone after intracerebroventricular injection of TNF. J Immunol 1996;157:5563–8
   PubMed Web of Science ®Google Scholar
• Wrotek S, Kamecki K, Kwiatkowski S, Kozak W. Cancer patients report a history of fewer fevers during infections than healthy controls. J Pre-Clin Clin Res 2009;3:31–5
   Google Scholar
• O’Regan B, Hirshberg C. Spontaneous Remission: An Annotated Bibliography. Petaluma, CA: Institute of Noetic Sciences, 1993
   Google Scholar
• Maurer S, Koelmel K. Spontaneous regression of advanced malignant melanoma. Onkologie 1998;21:14–18
   Web of Science ®Google Scholar
• Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ. High dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 1992;10:52–60
   PubMed Web of Science ®Google Scholar
• Yang JC, Topalian SL, Parkinson D, Schwartzentruber DJ, Weber JS, Ettinghausen SE, et al. Randomized comparison of high-dose and low-dose intravenous interleukin-2 for the therapy of metastatic renal cell carcinoma: An interim report. J Clin Oncol 1994;12:1572–6
   PubMed Web of Science ®Google Scholar
• Baronzio GF, Hager DE. Hyperthermia in Cancer Treatment: A Primer. New York: Springer, 2006
   Google Scholar
• Hobohm U. Fever therapy revisited. Br J Cancer 2005;92:421–5
   PubMed Web of Science ®Google Scholar
• Hobohm U. Fever and cancer in perspective. Cancer Immunol Immunother 2001;50:391–6
   PubMed Web of Science ®Google Scholar
• Kleef R, Hager ED. Fever, Pyrogens and Cancer. Madame Curie Bioscience Database. Austin, TX: Landes Bioscience, 2000, pp. 276–337
   Google Scholar
• Køstner AH, Johansen RF, Schmidt H, Mølle I. Regression in cancer following fever and acute infection. Acta Oncol 2013;52:455–7
   PubMed Web of Science ®Google Scholar
• Toraya-Brown S, Fiering S. Local tumour hyperthermia as immunotherapy for metastatic cancer. Int J Hyperthermia 2014;30:531–9
   PubMed Web of Science ®Google Scholar
• Hobohm U, Stanford JL, Grange J M. Pathogen-associated molecular pattern in cancer immunotherapy. Crit Rev Immunol 2008;28:95–107
   PubMed Web of Science ®Google Scholar
• Roberts NJ Jr. Impact of temperature elevation on immunologic defenses. Rev Infect Dis 1991;13:462–72
   PubMedGoogle Scholar
• Evans SS, Wang WC, Bain MD, Burd R, Ostberg JR, Repasky EA. Fever-range hyperthermia dynamically regulates lymphocyte delivery to high endothelial venules. Blood 2001;97:2727–33
   PubMed Web of Science ®Google Scholar
• Fisher DT, Vardam TD, Muhitch JB, Evans SS. Fine-tuning immune surveillance by fever-range thermal stress. Immunol Res 2010;46:177–88
   PubMed Web of Science ®Google Scholar
• Skitzki JJ, Repasky EA, Evans SS. Hyperthermia as an immunotherapy strategy for cancer. Curr Opin Investig Drugs 2009;10:550–8
   PubMed Web of Science ®Google Scholar
• Kalamida D, Karagounis IV, Mitrakas A, Kalamida S, Giatromanolaki A, Koukourakis MI. Fever-range hyperthermia vs. hypothermia effect on cancer cell viability, proliferation and HSP90 expression. PloS One 2015;10:1–12
   Google Scholar
• Burd R, Dziedzic TS, Xu Y, Caligiuri MA, Subjeck JR, Repasky EA. Tumor cell apoptosis, lymphocyte recruitment and tumor vascular changes are induced by low temperature, long duration (fever-like) whole body hyperthermia. J Cell Physiol 1998;177:137–47
   PubMed Web of Science ®Google Scholar
• Matsuda H, Strebel FR, Kaneko T, Danhauser LL, Jenkins GN, Toyota N, et al. Long duration-mild whole body hyperthermia of up to 12 hours in rats: Feasibility, and efficacy on primary tumour and axillary lymph node metastases of a mammary adenocarcinoma: Implications for adjuvant therapy. Int J Hyperthermia 1997;13:89–98
   PubMed Web of Science ®Google Scholar
• Rowe RW, Strebel FR, Proett JM, Deng W, Chan D, He G, et al. Fever-range whole body thermotherapy combined with oxaliplatin: A curative regimen in a pre-clinical breast cancer model. Int J Hyperthermia 2010;26:565–76
   PubMed Web of Science ®Google Scholar
• Zhang HG, Mehta K, Cohen P, Guha C. Hyperthermia on immune regulation: A temperature’s story. Cancer Lett 2008;271:191–204
   PubMed Web of Science ®Google Scholar
• Ostberg JR, Repasky EA. Emerging evidence indicates that physiologically relevant thermal stress regulates dendritic cell function. Cancer Immunol Immunother 2005;55:292–8
   PubMed Web of Science ®Google Scholar
• Mikucki ME, Fisher DT, Ku AW, Appenheimer MM, Muhitch JB, Evans SS. Preconditioning thermal therapy: Flipping the switch on IL-6 for anti-tumour immunity. Int J Hyperthermia 2013;29:464–73
   PubMed Web of Science ®Google Scholar
• Dayanc BE, Bansal S, Gure AO, Gollnick S, Repasky EA. Enhanced sensitivity of colon tumor cells to natural killer cell cytotoxicity after mild thermal stress is regulated through HSF-1 mediated expression of MICA. Int J Hyperthermia 2013;29:480–90
   PubMed Web of Science ®Google Scholar